Texas Agency Gives Go-Ahead To Experimental Stem Cell Use

Law360, New York (April 13, 2012, 6:10 PM EDT) -- The Texas Medical Board on Friday voted to approve controversial new rules to allow the experimental use of stem cell treatments in clinical trials approved by the U.S. Food and Drug Administration or the Institutional Review Board, a local research ethics review board.

The new rules — which the board approved by a 10-4 vote following Gov. Rick Perry’s stem cell treatment by a Houston doctor last summer — will require the FDA or the IRB to scrutinize such clinical trials for their ethical framework and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.